Cancer Institute of New Jersey at Cooper University Hospital - Camden — Camden, New Jersey

Cancer Institute of New Jersey at Cooper University Hospital - Camden is a clinical research site located in Camden, New Jersey, United States 08103.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Cancer Institute of New Jersey at Cooper University Hospital - Camden has participated in 12 clinical trials.

Therapeutic areas: Osteoporosis, Prostate Cancer, Head and Neck Cancer.

Sponsors: Radiation Therapy Oncology Group.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Institute of New Jersey at Cooper University Hospital - Camden?

Cancer Institute of New Jersey at Cooper University Hospital - Camden has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Institute of New Jersey at Cooper University Hospital - Camden conducted?

Cancer Institute of New Jersey at Cooper University Hospital - Camden has 12 clinical trials on record. Their work covers Osteoporosis, Prostate Cancer, Head and Neck Cancer.

Is Cancer Institute of New Jersey at Cooper University Hospital - Camden accredited by Crixeo Health?

Yes — Cancer Institute of New Jersey at Cooper University Hospital - Camden holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Cancer Institute of New Jersey at Cooper University Hospital - Camden?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.